Bausch + Lomb Corporation (BLCO) Financials
BLCO Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 13.3 billion | 6.6 billion |
2023-12-31 | 13.4 billion | 6.5 billion |
2023-09-30 | 13.1 billion | 6.2 billion |
2023-06-30 | 11.3 billion | 4.3 billion |
BLCO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -26.0 million | 19.0 million |
2023-12-31 | -69.0 million | 16.0 million |
2023-09-30 | 18.0 million | 16.0 million |
2023-06-30 | -54.0 million | 18.0 million |
BLCO Net Income
No data available :(
BLCO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 315.0 million | - | - |
2023-12-31 | 331.0 million | - | - |
2023-09-30 | 355.0 million | - | - |
2023-06-30 | 384.0 million | 2.6 billion | - |
BLCO Shares Outstanding
BLCO Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 67.0 million | 82.0 million | 504.0 million | - |
2023-12-31 | 84.0 million | 80.0 million | 108.0 million | 375.0 million |
2023-09-30 | 30.0 million | 82.0 million | 418.0 million | - |
2023-06-30 | 30.0 million | 85.0 million | 417.0 million | - |
BLCO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 1.1 billion | 424.0 million |
2023-12-31 | 1.2 billion | 461.0 million |
2023-09-30 | 1.0 billion | 392.0 million |
2023-06-30 | 1.0 billion | 417.0 million |
BLCO
Price: $13.60
52 week price:
Earnings Per Share: -0.74 USD
P/E Ratio: -24.17
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 494000
Market Capitalization: 4.9 billion